• Study finds healthy-appearing lupus skin

    From ScienceDaily@1:317/3 to All on Tue May 3 22:30:42 2022
    Study finds healthy-appearing lupus skin predisposed to flares, rashes
    In patients with lupus, immune cells undergo an inflammatory
    transformation when migrating from the blood to the skin

    Date:
    May 3, 2022
    Source:
    Michigan Medicine - University of Michigan
    Summary:
    A new study finds that the normal-appearing skin of lupus patients
    contains the same inflammatory signals that are detected when the
    skin develops a rash, sometimes at even higher levels. Researchers
    say immune cells undergo an inflammatory transformation that primes
    the skin without rashes for disease flares.



    FULL STORY ========================================================================== People with lupus have overactive immune systems that attack their own
    tissue, causing inflammation throughout the body.


    ========================================================================== Around 70-80% of them will develop skin disease as part of their
    condition. And while it's thought that exposure to ultraviolet light
    triggers the rashes, scientists are not sure how it ties together with
    the systemic inflammation.

    A Michigan Medicine study now brings more clarity, as researchers found
    that the normal-appearing skin of lupus patients contains the same
    inflammatory signals that are detected when the skin develops a rash -- sometimes at even higher levels. The results are published in Science Translational Medicine.

    "This really starts to piece the puzzle together of how inflammation seen
    in lupus patients may be related to skin exposures such as UV light,"
    said J.

    Michelle Kahlenberg, M.D., Ph.D., senior author of the study and
    rheumatologist at University of Michigan Health. "We were able to see
    the properties of normal-appearing skin in unparalleled resolution,
    suggesting that the skin is primed for inflammatory reactions." The team
    of researchers used single-cell RNA-sequencing analysis to assess the
    biopsies of both normal-appearing skin and skin from rashes of seven
    lupus patients. The results reveal that elevated signals of interferon,
    a protein known to contribute to UV sensitivity, were robustly present in
    all lupus biopsies compared to healthy control skin -- with the strongest signal coming from the healthy-appearing skin, not the inflamed skin.

    These interferon-rich inflammatory properties weren't just found
    in the keratinocytes, the cells that make up the epidermis of the
    skin. Researchers saw the same inflammatory changes in the fibroblasts
    that generate the connective tissue of the skin.



    ========================================================================== "This is really important because we have a new drug that can block
    interferon signaling in lupus, and people are trying to figure out how
    best to use that medication," said Kahlenberg, who is also an associate professor of rheumatology at U-M Medical School. "So, validating
    this abnormality in the interferon pathway could be essential for
    determining the best course of treatment for scores of lupus patients."
    Cell education The researchers also took blood samples of the same
    patients to examine how immune cells are promoting skin inflammation
    in lupus. Their data suggest that a subtype of monocytes, important
    members of the innate immune system, are exiting the blood into the skin
    of lupus patients. Upon moving into the skin, they undergo a striking inflammatory transformation.

    Kahlenberg calls it "cell education." The lupus skin environment itself
    - - specifically, the interferon within the skin -- appears to change
    the monocytes in a way that sets up the rest of the immune system to be
    turned on.

    Interferon plays a critical role in the innate immune system. It alerts
    the cells to dangerous invaders such as viruses. In many autoimmune
    diseases, however, interferon is overproduced in the absence of any real threat, changing how immune cells behave.



    ========================================================================== "These interferon-educated immune cells seem to be priming many different
    cell types in the skin to overreact to stimuli with excessive inflammatory responses, manifesting as disfiguring skin lesions," said Allison
    C. Billi, M.D., Ph.D., co-first author of the study, dermatologist
    at U-M Health and assistant professor of dermatology at U-M Medical
    School. "We don't yet know all of the stimuli that can tip the balance
    and precipitate these rashes, but UV light certainly appears to be one
    of them." Previous research analyzing the blood of lupus patients has struggled to identify potential biomarkers for disease flares. Knowing
    that the monocytes became more inflammatory when traveling to the skin, Kahlenberg believes the same process could also trigger systemic immune
    flares in other organs affected by lupus, such as the kidney and brain.

    "In future studies, we will want to look at these target organs to
    really understand what's going on," she said. "These cells transformed
    so robustly when they migrated into the skin it suggests that if we look
    for biomarkers only in the blood, we will likely miss what is really
    happening in the organs." Billi says understanding changes at a cellular
    level will enable precision medicine in lupus patients, which would employ individualized analysis to guide medical decisions and treatment options.

    "Research has been hampered by how differently lupus presents across individuals," she said. "By focusing on patients with lupus affecting
    a single organ -- the skin -- we have gained some insight into which
    cells are orchestrating lupus inflammation and how." Additional authors include Olesya Plazyo, Ph.D., Mehrnaz Gharaee-Kermani, DVM, Ph.D.,
    Rachael Wasikowski, M.S., Grace A. Hile, M.D., Xianying Xing, M.D.,
    Christine M. Yee, B.S., Syed M. Rizvi, DVM, M.S., Ph.D., Mitra P. Maz,
    Celine C. Berthier, Ph.D., Fen Wen, Ph.D., Lam C. Tsoi, Ph.D., Johann
    E. Gudjonsson, M.D., Ph.D., all of Michigan Medicine.

    From the University of California Los Angeles: Feiyang Ma, Ph.D., Matteo Pellegrini, Ph.D., Robert L. Modlin, M.D.


    ========================================================================== Story Source: Materials provided by
    Michigan_Medicine_-_University_of_Michigan. Original written by Noah
    Fromson. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Allison C. Billi, Feiyang Ma, Olesya Plazyo, Mehrnaz
    Gharaee-Kermani,
    Rachael Wasikowski, Grace A. Hile, Xianying Xing, Christine
    M. Yee, Syed M. Rizvi, Mitra P. Maz, Celine C. Berthier, Fei
    Wen, Lam C. Tsoi, Matteo Pellegrini, Robert L. Modlin, Johann
    E. Gudjonsson, J. Michelle Kahlenberg. Nonlesional lupus skin
    contributes to inflammatory education of myeloid cells and primes
    for cutaneous inflammation. Science Translational Medicine, 2022;
    14 (642) DOI: 10.1126/scitranslmed.abn2263 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2022/05/220503083003.htm

    --- up 9 weeks, 1 day, 10 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)